Jason Pharmaceuticals, Inc.

Baltimore, MD ManufacturingNAICS 311900

Self-funded health planPlan year 2025Renews January
628Participants-9% vs. prior year
$1.5MEst. pharmacy spend / yrParticipants × national avg.
Jan 2027Next renewalPlan year begins January 1
#16 of 19Manufacturing in MDBy participants

Overview

Jason Pharmaceuticals, Inc. sponsors a self-funded health plan that covered 628 participants in plan year 2025, down 9% from the prior year. The plan year starts in January. Alongside medical, its benefits filing reports life insurance, dental, vision, long-term disability, and more.

Plan type
ERISA welfare benefit plan, self-funded (benefits paid from employer assets or a trust)
Participants
628 · prior year 691
Plan year
Begins January 1 · next renewal January 2027
Health plans filed
The Medifast Employee Benefits Plan, plan 501 (628 participants)
Broker compensation
$10K across insured contracts
MedicalLife insuranceDentalVisionLong-term disabilityDeath benefits

Insurance carriers

Insured coverage reported on Schedule A. Self-funded medical claims aren't reported there.

CarrierCoverageCoveredPremiumBroker comp
Unum Life Insurance Company of AmericaLife, Long-term disability434$208K$10K
Aetna Life Insurance Co.Vision538$36K—
Janus Associates, Inc. DBA BHSEmployee Assistance Program620$17K—

Pharmacy benefit estimate

StreamRX estimate for a plan this size. Not based on this plan's claims.

$1.5M/ year

Estimated prescription spend: 628 participants × $2,371 national average per member. Usually higher once dependents are counted.

$39K–$95K/ year

Typical savings opportunity found in independent reviews of plans this size.

Brands with a generic available$11K–$28K
Lower-cost therapeutic alternatives$17K–$35K
Generic pricing vs. actual cost$7K–$21K
PBM contract terms$4K–$11K
The DOL's PBM fee disclosure rule first applies to this plan for the plan year beginning January 2028: semiannual PBM compensation reports and an annual audit right.

Form 5500 filing details

Filing
Form 5500 with Schedule A, plan year 2025
Plan sponsor
Jason Pharmaceuticals, Inc.
Sponsor EIN
52-1237423
Plan number
501
Filed with
U.S. Department of Labor (EBSA) via EFAST2

Verify this filing: search EIN 52-1237423 in the Department of Labor's EFAST2 Form 5500 search.

Retirement plan

Plan
Medifast, Inc. 401(k) Plan
Type
401(k) plan
Participants
847

About this data

Source: Jason Pharmaceuticals, Inc.'s Form 5500 filing for plan year 2025 and its Schedule A insurance reports, published by the U.S. Department of Labor. "Self-funded" means the filing reports benefits paid from employer assets or a trust, with no medical insurance contract or with a stop-loss contract. Pharmacy figures are StreamRX estimates based on national averages. StreamRX is not affiliated with Jason Pharmaceuticals, Inc..

Request a correction · Methodology